New Step by Step Map For Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors from the central anxious method, conolidine modulates alternate molecular targets. A Science Developments review identified that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXC